The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population

Clinical Endocrinology

Volumn 77, Issue 5, 2012, Pages 699-706

  Jung, Chang Hee ^a   Hwang, Jenie Yoonoo ^a   Yu, Ji Hee ^a   Shin, Mi Seon ^a   Bae, Sung Jin ^a   Park, Joong Yeol ^a   Kim, Hong Kyu ^a   Lee, Woo Je ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84867247082     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04329.x     Document Type: Article

References (35)

1. Alberti, K.G., Zimmet, P., &, Shaw, J., (2005) The metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-1062. (Pubitemid 41338752)
2. Ford, E.S., Giles, W.H., &, Mokdad, A.H., (2004) Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care, 27, 2444-2449. (Pubitemid 39281399)
3. Duncan, G.E., Li, S.M., &, Zhou, X.H., (2004) Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care, 27, 2438-2443. (Pubitemid 39281398)
4. Park, Y.W., Zhu, S., Palaniappan, L., et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine, 163, 427-436. (Pubitemid 36241019)
5. Lim, S., Shin, H., Song, J.H., et al. (2011) Increasing prevalence of metabolic syndrome in Korea: the korean national health and nutrition examination survey for 1998-2007. Diabetes Care, 34, 1323-1328.
6. Davidson, M.H., (2009) Apolipoprotein measurements: is more widespread use clinically indicated? Clinical Cardiology, 32, 482-486.
7. Marcovina, S.M., Albers, J.J., Kennedy, H., et al. (1994) International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clinical Chemistry, 40, 586-592.
8. Walldius, G., &, Jungner, I., (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. Journal of Internal Medicine, 259, 493-519.
9. Walldius, G., Jungner, I., Holme, I., et al. (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet, 358, 2026-2033. (Pubitemid 34084825)
10. Yusuf, S., Hawken, S., Ounpuu, S., et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364, 937-952. (Pubitemid 39208455)
11. Kastelein, J.J., van der Steeg, W.A., Holme, I., et al. (2008) Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation, 117, 3002-3009.
12. Sniderman, A.D., Furberg, C.D., Keech, A., et al. (2003) Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet, 361, 777-780. (Pubitemid 36293636)
13. McQueen, M.J., Hawken, S., Wang, X., et al. (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet, 372, 224-233. (Pubitemid 351978112)
14. Sierra-Johnson, J., Somers, V.K., Kuniyoshi, F.H., et al. (2006) Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. American Journal of Cardiology, 98, 1369-1373. (Pubitemid 44666643)
15. Sierra-Johnson, J., Romero-Corral, A., Somers, V.K., et al. (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. European Heart Journal, 28, 2637-2643. (Pubitemid 350071512)
16. Alfadda, A.A., Al-Daghri, N.M., &, Malabu, U.H., (2008) Apolipoprotein B/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus. Saudi Medical Journal, 29, 821-825.
17. Pitsavos, C., Panagiotakos, D.B., Skoumas, J., et al. (2008) Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study. Angiology, 59, 335-341. (Pubitemid 351793161)
18. Zhong, L., Li, Q., Jiang, Y., et al. (2010) The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population. Inflammation, 33, 353-358.
19. Wallenfeldt, K., Bokemark, L., Wikstrand, J., et al. (2004) Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke, 35, 2248-2252. (Pubitemid 39311244)
20. Enkhmaa, B., Anuurad, E., Zhang, Z., et al. (2010) Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. American Journal of Cardiology, 106, 1264-1269.
21. Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752. (Pubitemid 41532612)
22. Marcovina, S., &, Packard, C.J., (2006) Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. Journal of Internal Medicine, 259, 437-446.
23. Lind, L., Vessby, B., &, Sundstrom, J., (2006) The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 406-410. (Pubitemid 43732207)
24. Rashid, S., Patterson, B.W., &, Lewis, G.F., (2006) Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans? Journal of Lipid Research, 47, 1631-1642. (Pubitemid 44222815)
25. Festa, A., D'Agostino, R., Howard, G., et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 102, 42-47. (Pubitemid 30430551)
26. Sattar, N., Williams, K., Sniderman, A.D., et al. (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation, 110, 2687-2693. (Pubitemid 39453020)
27. Esposito, K., &, Giugliano, D., (2004) The metabolic syndrome and inflammation: association or causation? Nutrition, Metabolism, and Cardiovascular Diseases, 14, 228-232. (Pubitemid 39611863)
28. Onat, A., Can, G., Cicek, G., et al. (2010) Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study. Clinical Biochemistry, 43, 1381-1386.
29. Harjai, K.J., (1999) Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen. Annals of Internal Medicine, 131, 376-386. (Pubitemid 29424632)
30. Abramson, J.L., Hooper, W.C., Jones, D.P., et al. (2005) Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis, 178, 115-121. (Pubitemid 39600823)
31. Onat, A., Can, G., Hergenc, G., et al. (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. International Journal of Obesity (London), 31, 1119-1125. (Pubitemid 46987762)
32. Matthan, N.R., Jalbert, S.M., Lamon-Fava, S., et al. (2005) TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1691-1696. (Pubitemid 41098942)
33. James, W.P., Chunming, C., &, Inoue, S., (2002) Appropriate Asian body mass indices? Obesity Reviews, 3, 139. (Pubitemid 34815231)
34. Onat, A., Hergenc, G., Bulur, S., et al. (2010) The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. International Journal of Cardiology, 142, 72-79.
35. Onat, A., Can, G., Ayhan, E., et al. (2009) Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Metabolism, 58, 1393-1399.